10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
PFIZER INC | ||
Ticker: PFE Fiscal Year: 2019 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2019 10-K (Filed: Feb 27, 2020) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2019 | Dec 31, 2018 | |
| Assets | ||
| Cash and cash equivalents | $ 1,305 | 1,139 |
| Short-term investments | 8,525 | 17,694 |
| Trade accounts receivable, less allowance for doubtful accounts: 2019$527; 2018$541 | 8,724 | 8,025 |
| Inventories | 8,283 [1] | 7,508 |
| Current tax assets | 3,344 | 3,374 |
| Other current assets | 2,600 | 2,461 |
| Assets held for sale | 21 | 9,725 |
| Total current assets | 32,803 | 49,926 |
| Equity-method investments | 17,133 | 181 |
| Long-term investments | 3,014 | 2,586 |
| Property, plant and equipment, less accumulated depreciation | 13,967 | 13,385 |
| Identifiable intangible assets, less accumulated amortization | 35,370 | 35,211 |
| Goodwill | 58,653 | 53,411 |
| Noncurrent deferred tax assets and other noncurrent tax assets | 2,099 | 1,924 |
| Other noncurrent assets | 4,450 | 2,799 |
| Total assets | 167,489 | 159,422 |
| Liabilities and Equity | ||
| Short-term borrowings, including current portion of long-term debt: 2019$1,462; 2018$4,776 | 16,195 | 8,831 |
| Trade accounts payable | 4,220 | 4,674 |
| Dividends payable | 2,104 | 2,047 |
| Income taxes payable | 980 | 1,265 |
| Accrued compensation and related items | 2,720 | 2,397 |
| Other current liabilities | 11,083 | 10,753 |
| Liabilities held for sale | 0 | 1,890 |
| Total current liabilities | 37,304 | 31,858 |
| Long-term debt | 35,955 | 32,909 |
| Pension benefit obligations, net | 5,638 | 5,272 |
| Postretirement benefit obligations, net | 1,124 | 1,338 |
| Noncurrent deferred tax liabilities | 5,578 | 3,700 |
| Other taxes payable | 12,126 | 14,737 |
| Other noncurrent liabilities | 6,317 | 5,850 |
| Total liabilities | 104,042 | 95,664 |
| Commitments and Contingencies | ||
| Preferred stock, no par value, at stated value; 27 shares authorized; issued: 2019431; 2018478 | 17 | 19 |
| Common stock, $0.05 par value; 12,000 shares authorized; issued: 20199,369; 20189,332 | 468 | 467 |
| Additional paid-in capital | 87,428 | 86,253 |
| Treasury stock, shares at cost: 20193,835; 20183,615 | (110,801) | (101,610) |
| Retained earnings | 97,670 | 89,554 |
| Accumulated other comprehensive loss | (11,640) | (11,275) |
| Total Pfizer Inc. shareholders equity | 63,143 | 63,407 |
| Equity attributable to noncontrolling interests | 303 | 351 |
| Total equity | 63,447 | 63,758 |
| Total liabilities and equity | 167,489 | 159,422 |
| [1] The change from December 31, 2018 reflects increases for certain products, including inventory build for new product launches, supply recovery and market demand, partially offset by a decrease due to foreign exchange and the write off of rivipansel inventory previously expected to be sold (see Note 2E). | ||
| External Links | |
| PFIZER INC (PFE) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |